Diabetes Research
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP).
Are at least 18 years old or older at time of ICF signature
Have Type 1 Diabetes or Type 2 Diabetes for at least 6 months prior to screening
Have a stable glycemic control on stable diabetes treatment regimen for at least 90 days prior to day 1 with a hemoglobin A1c (HbA1c) ≤10 for T1D and HbA1c ≤11 for participants with T2D at time of screening
Are willing to discontinue all medications taken for chronic pain conditions
Are willing to abide by reproductive and contraceptive requirements
Have history of painful neuropathies other than DPNP
Have symptomatic peripheral vascular disease
Have uncontrolled diabetes
Have a surgery planned
Have had cancer in past 2 years
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.